Doris Ponce, MD
Memorial Sloan Kettering Cancer Center · MSKCC
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Doris Ponce, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:04 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07913672 · A Study of LBP-MARCO and Ruxolitinib in People With Graft-Versus-Host Disease (GVHD)Memorial Sloan Kettering Cancer Center · recruiting · Transplant Failure or Rejection of Bone Marrow (Graft vs Host Disease, GVHD) · principal investigator
- Ph2NCT07359859 · A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell TransplantMemorial Sloan Kettering Cancer Center · recruiting · Hematologic Malignancies · principal investigator
- Ph2NCT07006506 · A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell TransplantMemorial Sloan Kettering Cancer Center · recruiting · Graft Versus Host Disease, Graft Vs Host Disease, Hematologic Malignancy · principal investigator
- Ph1NCT04995653 · A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCTSeres Therapeutics, Inc. · completed · Allogeneic Hematopoietic Stem Cell Transplantation · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:04 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.